XETR
CHG
Market cap259mUSD
Sep 25, Last price
13.70EUR
Name
MEDIQON Group AG
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating across the DACH region, MEDIQON Group AG and its subsidiaries specialize in delivering a diverse portfolio of software solutions. Their offerings encompass general management platforms, specialized practice management tools for veterinarians, modular systems tailored for sheet metal processing businesses, and applications supporting building-related services. Furthermore, MEDIQON develops software for construction process management, comprehensive enterprise resource planning (ERP) systems covering core functions like sales, procurement, inventory, customer relationship management, and financial accounting, alongside bespoke ERP solutions for mid-sized enterprises. A notable product is Atlantis, their school administration software. Beyond its digital services, the group diversifies its operations by running a language school, managing the import and distribution of cable protection products, and providing expert services in the design, consultation, and installation of refrigeration, air conditioning, and air purification systems. Established in 1998 as medical Columbus AG, the company, now known as MEDIQON Group AG, is headquartered in Königstein, Germany.
Related entities
Subsidiaries (4)
NGC Nachfolgekapital GmbH
GfW Gesellschaft für Weiterbildung mbH
OSW 13 CZK Ookam s.r.o.
Vortex Software GmbH
Key people
Mathias Saggau
Chairman of the Supervisory Board · since 2018
Dirk Isenberg
Sole Member of the Management Board
Manfred Hellwig
Chairman of the Supervisory Board · since 2008
Andre Angermueller
Member of the Supervisory Board · since 2013
Till Moysies
Member of the Supervisory Board · since 2016
Robert Schlick
Member of the Supervisory Board · since 2011
Headquarters & legal address
Falkenried 29
Hamburg, HH 20251
DE
Hamburg, HH 20251
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||